Factors contributing to mammography failure in women aged 40-49 years

Journal of the National Cancer Institute

Volumn 96, Issue 19, 2004, Pages 1432-1440

  Buist, Diana S M ^a,b   Porter, Peggy L ^c,d   Lehman, Constance ^c,d,e   Taplin, Stephen H ^f   White, Emily ^b,c  

^a CENTER FOR HEALTH STUDIES   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e SEATTLE CANCER CARE ALLIANCE   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; GROUPS BY AGE; GROWTH RATE; HUMAN; IMAGE QUALITY; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RADIOSENSITIVITY; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; AGE; BREAST TUMOR; MASS SCREENING; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; RISK; SENSITIVITY AND SPECIFICITY; STANDARD;

ADULT; AGE FACTORS; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 6944236437     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh269     Document Type: Article

References (40)

1. Brekelmans CT, Peeters PH, Faber JA, Deurenberg JJ, Collette HJ. The epidemiological profile of women with an interval cancer in the DOM screening programme. Breast Cancer Res Treat 1994;30:223-32.
2. Ernster VL. Mammography screening for women aged 40 through 49 - a guidelines saga and a clarion call for informed decision making. Am J Public Health 1997;87:1103-6.
3. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 1995;75:2507-17.
4. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138:168-75.
5. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137(5 Part 1):347-60.
6. International Agency for Research on Cancer (IARC). Breast cancer screening. In: Vainio H, Bianchini F, editors. Handbook of cancer prevention. Vol 7. Lyon (France: IARC Press; 2002.
7. Ringash J. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. CMAJ 2001;164:469-76.
8. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-2.
9. El-Bastawissi AY, White E, Mandelson MT, Taplin SH. Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control 2000;11:955-63.
10. Wolfe JN. Breast parenchymal patterns and their changes with age. Radiology 1976;121(3 Pt. 1):545-52.
11. Day NE. Screening for breast cancer. Br Med Bull 1991;47:400-15.
12. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276:33-8.
13. Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst 1992;84:781-5.
14. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000;92:1081-7.
15. Taplin SH, Rutter CM, Finder C, Mandelson MT, Houn F, White E. Screening mammography: clinical image quality and the risk of interval breast cancer. AJR Am J Roentgenol 2002;178:797-803.
16. Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 1999;91:2020-8.
17. Gilliland FD, Joste N, Stauber PM, Hunt WC, Rosenberg R, Redlich G, et al. Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 2000;92:743-9.
18. Brekelmans CT, van Gorp JM, Peeters PH, Collette HJ. Histopathology and growth rate of interval breast carcinoma. Characterization of different subgroups. Cancer 1996;78:1220-8.
19. Brekelmans CT, Westers P, Faber JA, Peeters PH, Collette HJ. Age specific sensitivity and sojourn time in a breast cancer screening programme (DOM) in The Netherlands: a comparison of different methods. J Epidemiol Community Health 1996;50:68-71.
20. Duffy SW, Chen HH, Tabar L, Fagerberg G, Paci E. Sojourn time, sensitivity and positive predictive value of mammography screening for breast cancer in women aged 40-49. Int J Epidemiol 1996;25:1139-45.
21. Taplin SH, Thompson RS, Schnitzer F, Anderman C, Immanuel V. Revisions in the risk-based Breast Cancer Screening Program at Group Health Cooperative. Cancer 1990;66:812-8.
22. Taplin SH, Mandelson MT, Anderman C, White E, Thompson RS, Timlin D, et al. Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a population. Cancer Epidemiol Biomarkers Prev 1997;6:625-31.
23. Breast Imaging Reporting and Data System (BI-RADS). 3rd ed. Reston (VA): American College of Radiology; 1998. Available at: http://imaginis.com/pro/breast_imag_resrc/acr-birads.asp. [Last accessed: August 18, 2004.]
24. U.S. Preventive Services Task Force. Screening for breast cancer. Rockville (MD): U.S, Department of Health and Human Services, Agency for Healthcare Research and Quality; 2002; Publ No. 02-507A. p. 1-9.
25. U.S. Department of Health and Human Services (DHHS), Food and Drug Administration. Quality mammography standards. Final rule. 21 CFR Parts 16 and 900 [Docket No. 95N-0192]. RIN 0910-AA24. Washington (DC): DHHS; Oct. 1997.
26. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19; 403-410. Histopathology 2002;41:151.
27. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997;3:222-5.
28. Oestreicher N, White E, Malone KE, Porter PL. Hormonal factors and breast tumor proliferation: do factors that affect cancer risk also affect tumor growth? Breast Cancer Res Treat 2004;85:133-42.
29. Bray GA. Overweight is risking fate. Definition, classification, prevalence, and risks. Ann N Y Acad Sci 1987;499:14-28.
30. Tarver-Carr ME, Powe NR, Eberhardt MS, LaVeist TA, Kington RS, Coresh J, et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol 2002;13:2363-70.
31. Smith RA. Breast cancer screening among women younger than age 50: a current assessment of the issues. CA Cancer J Clin 2000;50:312-36.
32. Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 2002; 11(10 Pt 1):1048-53.
33. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995;87:1622-9.
34. Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol 1997;169:1001-8.
35. General Accounting Office (GAO). Mammography services: impact of federal legislation on quality, access, and health outcomes. Washington DC): GAO; 1997. Publ No. GAO/HEHS-98-11.
36. Crosier M, Scott D, Wilson RG, Griffiths CD, May FE, Westley BR. Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers. Clin Cancer Res 1999;5:2682-8.
37. Ernst MF, Roukema JA, Coebergh JW, Repelaer van Driel OJ, van Beek MW, van der Sangen MJ, et al. Breast cancers found by screening: earlier detection, lower malignant potential or both? Breast Cancer Res Treat 2002;76:19-25.
38. Taplin SH, Ichikawa L, Buist DS, Seger D, White E. Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev 2004;13:225-34.
39. Freer TW, Ulissey MJ. Screening mammography with computer-aided detection: prospective study of 12,860 patients in a community breast center. Radiology 2001;220:781-6.
40. Stoutjesdijk MJ, Boetes C, Jager GJ, Beex L, Bult P, Hendriks JH, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001;93:1095-102.